Outlining the implications of this c-suite trend for pharma.
Michael Abrams, MA
Advertisement
Articles by Michael Abrams, MA
Commercial-model shift demanding greater influence of these teams.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
What Pharma Marketers Need to Know About Recent Gartner Predictions About AI and What It Means to Them
2
What Governance Resets Should Pharma Companies Take in Response to AI?
3
FDA Approves Icotyde as Treatment of Moderate-to-Severe Plaque Psoriasis in Adults and Adolescents
4
TrumpRx Selling Medicines at Higher Prices Than Other Countries: Report
5